Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-15

  1. 863 Posts.
    lightbulb Created with Sketch. 425
    That's right. Zero humans. Lots of rats and mice.

    Hundreds of thousands of compounds have shown amazing promise in mice and rats that just don't translate to humans. Every big pharma has thousands of such compounds under investigation.

    We have no idea about effectiveness in humans. We have no idea of safety in humans.

    And there is no "non dillutive" funding coming along. It's not "locked in".

    Why do you feel the need to compulsively post lies and misinformation? If the company had everything you said, the market would take care of it and we would all be rich.

    If anything, this is wildly overvalued for a preclinical hail mary lottery ticket with no pipeline or backup.

    They don't even have IP protection for their lead compound! No patents Benny!!


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
22.0¢
Change
-0.025(10.2%)
Mkt cap ! $46.40M
Open High Low Value Volume
24.5¢ 25.0¢ 22.0¢ $256.0K 1.085M

Buyers (Bids)

No. Vol. Price($)
3 67420 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 25083 2
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.